12:00 AM
 | 
Jan 21, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Pronova, Takeda sales and marketing update

Takeda launched Lotriga in Japan to treat hyperlipidemia. Takeda has exclusive, Japanese development and marketing rights to the omega-3-acid ethyl esters from Pronova under a 2005 deal. Takeda said the National Health Insurance...

Read the full 152 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >